Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 4242 Six Forks Road, Suite 820,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.pathalys.com
- HQ
- Raleigh, North Carolina
Pathalys Pharma Questions
Pathalys Pharma's website is https://www.pathalys.com
Pathalys Pharma's LinkedIn profile is https://www.linkedin.com/company/pathalys
Pathalys Pharma has
14 employees.
View email and phone details for 14
employees at Pathalys Pharma.
Pathalys Pharma's industry is
Biotechnology Research
Pathalys Pharma's top competitors are
Xii Medical,
Phathom Pharmaceuticals,
Precisedx,
Moleculin Biotech, Inc.,
Human Longevity, Inc.,
Avidity Biosciences, Inc.,
Mbx Biosciences, Inc.,
Kymera Therapeutics,
Borealis Biosciences, Inc.,
Vandria Sa.
Pathalys Pharma's categories are Biotechnology Research
Pathalys Pharma's founding year is 2021
